Furthermore, the exosome miR-590-3p from CAFs can enhance the resistance of CRC cells to radiation therapy through the CLCA4/PI3K/Akt axis, thus providing immunosuppression against tumor therapy [39]. This evidence concerns the gene AKT1 and colorectal carcinoma.